Sorry, registration has ended.

Faculty: Edwin Waldbusser ‎ ‎ ‎ ‎ ‎‎ ‎ ‎ |‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ Code: MD3396

  • Date: 2/6/2024 11:00 AM - 2/6/2024 12:00 PM
  • Time zone: Eastern Time (US/Canada) Online Event


This webinar will explain how to determine if your app is a medical device and if it will be subject to FDA cybersecurity requirements. The FDA approval process for mobile apps will be explained including FDA software validation requirements which are more extensive than just testing performance.

The FDA Guidance explains how they intend to apply their regulatory authority to software applications intended for mobile medical apps. They have defined what types of apps they consider a medical device. Apps that are medical devices must meet all FDA device requirements, however, FDA will not enforce their requirements on mobile apps that meet the FDA’s definition of a medical device but pose a low health risk.

Areas Covered in the Session :

  • What mobile apps are medical devices?
  • What areFDA regulated mobile apps?
  • How to get a mobile app approved by FDA?
  • Cybersecurity for mobile apps explained

Who Should Attend:

  • Development Engineers
  • Production Management
  • QA/ QC personnel
  • Software developers
  • IT personnel

Course Director: Edwin Waldbusser


Edwin Waldbusser retired from industry after 30 years in management of development of medical device products and development of company Quality Systems. He was involved in the development of products such as IVD devices, kidney dialysis systems and inhalation devices. His QS experience includes, design control, risk analysis, CAPA, software validation, supplier qualification/ control and manufacturing/non-conforming product programs. He now consults in the area of quality systems for medical devices with emphasis on design control, software validation, risk analysis and human factors analysis.

Ed has a B.S. Mechanical Engineering from NYU and a M.B.A from Drexel University. He is certified by Lloyds of London as an ISO 9000 Lead Auditor and is a member of the Thomson Reuters Expert Witness network. He has 5 issued patents.